Search

everythinglearnresearchcommunity

for

Search:↓

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

A new compound effectively inhibits human 5α-reductase 1.

Finasteride-treated male rats' offspring had altered glucose metabolism, potentially increasing diabetes risk.

A specific RNA molecule, circCOL1A1, affects the growth and quality of goat hair by interacting with miR-149-5p and influencing cell growth pathways.

Certain medications including flutamide, spironolactone, and others effectively reduce excessive hair growth in women, especially when combined with lifestyle changes.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

Adding fetal calf serum helps Merkel cells survive and change shape.

Genetic factors influence hair traits like shape, color, and greying in Latin Americans.

Certain inhibitors slow down plant growth by causing early cell specialization without changing the cell development pattern.

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Androgens block hair growth by disrupting cell signals; targeting GSK-3 may help treat hair loss.

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

5α-reductase inhibitors, like finasteride and dutasteride, effectively treat BPH, male baldness, and hirsutism, with potential for acne and prostate cancer prevention.

Fadrozole and Finasteride change frog sex ratios and cause intersex animals with altered gene expressions.

ADSC-CE treatment safely increases hair density and thickness in androgenetic alopecia patients.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

New hybrid compound found to effectively prevent hair loss.

Patients with severe alopecia areata have higher levels of MIF, which decrease after successful treatment.

Genomic approach finds new possible treatments for hair loss.

Finasteride negatively affects fish reproduction and gonadal development.

In 2017, Spanish dermatologists commonly prescribed topical minoxidil, oral finasteride, and nutricosmetics for hair loss, with oral contraceptives also used for premenopausal women. Less common were oral dutasteride, due to side effects, and newer, more expensive treatments like topical finasteride and Low-Level Laser Therapy. The conclusion is that there's a need for prescription guidelines due to varied treatment approaches.

Two teenage boys lost hair after taking a drug for growth, which was not a known side effect for kids.

Medicaid coverage for alopecia areata treatments is inconsistent and often limited.